Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
Clinical trial NCT07095465 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07095465
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-14
- Primary completion
- 2029-02-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.